INTRODUCTION
Tumor-infiltrating lymphocytes (TILs) are a part of the tumor surveillance system. 1 They are frequently present in solid human tumors, 2 and their role in different types of cancers has been controversial. The presence of TILs correlates with a better prognosis in several types of cancer, and each T-lymphocyte subset has a unique role in the antitumor response. [3] [4] [5] [6] [7] The presence of tumor-infiltrating cytotoxic T lymphocytes (CTLs) has been linked to better patient survival in endometrial, ovarian, pancreatic and colorectal cancers. [8] [9] [10] The role of CD4 1 T cells is more controversial and is often considered to be a double-edged immunologic sword because CD4
1 T cells play a central role in initiating and maintaining anticancer immune responses. [11] [12] [13] 
CD4
1 T-cell help is needed during the primary antigen-specific response to imprint CD8 1 T cells with the ability to develop into long-lived functional memory cells. 14 In antitumor immunity, CD4 1 T cells have also been shown to be important in sustaining the functions of adoptively transferred CD8 1 T cells. 15 On the other hand, naturally occurring subsets of CD4 1 T cells called regulatory T cells (Tregs) play an essential role in controlling immune responses to self-and non-self-antigens. Tumor-infiltrating Tregs have been reported to be associated with poor prognosis in some cancers because they suppress the proliferation of effector T lymphocytes (i.e., CTL), which prohibits an adequate tumor-specific immune response and enables tumor growth. [16] [17] [18] [19] [20] [21] In contrast, tumor-infiltrating Tregs have also been reported to be either associated with a better prognosis or not associated with prognosis in some malignancies such as follicular lymphoma and squamous cell carcinoma. [22] [23] [24] Antitumor immune responses are attributed mainly to cellmediated immunity. The activation of both CD4
1 and CD8 1 T lymphocytes is needed for an efficient immune response that destroys tumor cells. [11] [12] [13] 15 In this scenario, the infiltration of the tumor site with high numbers of CD8 1 TILs would be desirable. The presence of CD4
1 TILs would also be required because CD8 1 T cells usually need CD4
1 T cells to optimally function. The ratio of CD4 1 /CD8 1 T cells is likely a key parameter for appropriate TIL function; this ratio may be different for different types of cancer.
Recently, the immunogenicity of malignancy has been reappraised according to the type of immune response provoked by the tumor. In our previous study, we observed that highly immunogenic tumor cells in syngeneic mice can induce type I immune responses, whereas poorly immunogenic tumor cells induce type II immune responses. 25 Using an assay to determine the immune microenvironment of cervical cancer, others have shown a type II predominance. 26, 27 Cervical cancer is one of the most common malignancies of married women globally and is the result of an uncontrolled persistent infection with a high-risk human papillomavirus (HPV) type, HPV16 and HPV18 in particular, which account for approximately two-thirds of these cancers. 28, 29 The immune microenvironment of cervical cancer not only shares the nature of solid tumors in general, but also possesses the properties associated with its etiology. HPV may use different strategies to evade immune recognition. These characteristics make the microenvironment of cervical cancer more complicated.
In the present study, to examine the immune status of cervical carcinoma in situ by immunohistochemistry, we evaluated the status of CTLs and Tregs by characterizing their functional phenotypes (using granzyme B (GrB) and FOXP3) as markers of the immune response. This approach may contribute novel information to the field of cervical cancer immunology.
MATERIALS AND METHODS

Samples
Under the approval of the institutional review board and ethics committee, biopsy samples from 40 cervical cancer patients were collected from the First Affiliated Hospital of the Medical College of Xi'an Jiaotong University. All cases had follow-up data for at least 5 years. No cases received radiation or chemotherapy prior to operation but were treated with radiotherapy after diagnosis and biopsy collection. All cases were histopathologically classified according to the International Federation of Obstetrics and Gynecology (FIGO) criteria. The tissue samples were fixed in formalin and embedded in paraffin. All cases were positive for HPV by PCR. 30 
Immunohistochemistry
Immunohistochemistry staining was conducted on 4-to 5-mm paraffin sections using horseradish peroxidase from the Envision Kit or the Catalyzed Signal Amplification Kit (Dako Corporation, Copenhagen, Denmark) for single staining, and alkaline phosphatase was used for double staining, as recommended by the manufacturer. The primary antibodies were mouse monoclonal anti-human anti-CD8 (DakoCytomation, Glostrup, Denmark; 1 : 100 dilution), antiGrB (Novocastra, Newcastle, UK; 1 : 100), anti-Perforin (Prf; Novocastra; 1 : 20), anti-CD4 (Novocastra; 1 : 30), anti-OX40 (Novocastra; 1 : 50), anti-FOXP3 (Abcam, Cambridge, UK; 1 : 50), and anti-Ki67 (DakoCytomation; 1 : 200). Briefly, the sections were dewaxed in xylene and rehydrated using graded concentrations of ethanol and distilled water. Endogenous peroxidase activity was blocked by submersion of the sections in a 0.5% H 2 O 2 /methanol solution for 10 min at room temperature (RT). Antigen was retrieved by heating the sections under high temperature and pressure in a stainless steel pressure cooker for 1 min and 30 s in unmasking solution (0.01 M citrate buffer, pH 6.0). After cooling the cooker to RT in running tap water, the sections were placed in TBS-Tween buffer for 5 min, blocked with 3% goat serum for 10 min at 37 uC, and incubated with primary antibody (at RT: CD8, 1 h; GrB, 2 h; Prf, 2 h; OX40, 1 h; Ki67, 1 h; and CD4 overnight at 4 uC). After the sections were rinsed three times with TBS-Tween buffer, they were subsequently incubated with Dako EnVision (or AP 1 : 500 in the case of double staining) for 30 min or processed according to the instructions of the Catalyzed Signal Amplification Kit at RT. After the sections were washed with TBS-Tween buffer, the antigen-antibody reaction was visualized using 3,39-diaminobenzidine in the case of horseradish peroxidase and 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium in the case of AP, and the sections were counterstained with hematoxylin or methyl blue, respectively. Tonsil tissue was used as a positive control for all the antibodies. The numbers of labeled TILs were counted by the classical counting method with the light microscope using an ocular grid at 3200 magnification. Labeled cells were counted in the whole tissue section, and the total number of labeled cells was divided by the number of fields to calculate the mean value for each case. Counting was performed twice for each slide.
Statistical analysis
The non-parametric Wilcoxon signed-rank test was used to compare the mean number of TILs among the groups and subgroups. Followup time was calculated as the interval between the date of treatment Clinical outcome in squamous cell carcinoma W Shah et al 60 and last follow-up or death. Survival rates were analyzed with the Kaplan-Meier method using the log-rank test to assess the difference between survival curves. A P value of less than 0.05 was considered statistically significant. Statistical calculations were performed using SPSS version 14.0 for Windows.
RESULTS
Clinicopathological characteristics of patients
The clinicopathological characteristics of patients are provided in Table 1 . The immunohistochemical variables are provided in Table 2 . Among the 40 cases studied, five cases were not evaluable after staining, so they were excluded. The remaining 35 cases were evaluated. All data are shown as mean6SD.
Tumor-infiltrating CD8 T lymphocytes CD8
1 T lymphocytes ( Figure 1 ) were found in both the stroma and tumor nest. Independent of whether the samples were from the deceased or surviving groups, the mean number of CD8
1 T cells was lower in the stroma as compared with that in the tumor nest (21.06616.58 versus 34.53626.98, P50.039 and 22.57616.88 versus 33.51627.79, P50.050 in the deceased and surviving groups, respectively). Comparing the deceased and surviving groups, we observed no Clinical outcome in squamous cell carcinoma W Shah et al 61 significant differences in either the stroma or the tumor nest, and we also observed no significant differences in the overall mean number of CD8 1 T cells. When the patients were stratified by FIGO staging, the mean number of CD8 1 T cells was higher in the tumor nest as compared with that in the stroma ( 20.19614 Table 3 ). The functional status of CD8 1 T cells was evaluated using the expression of GrB and Prf. No significant differences were observed in the activated CTL either in the stroma or the tumor nest, nor overall in either group (decease or surviving, or FIGO IIB or IIIB groups; data not shown). As expected, the number of GrB 1 and Prf 1 TILs was consistent. When the survival rate was determined using the Kaplan-Meier method and when the patients were divided into two groups (low and high levels of CD8 1 T cells) based on the median value, no significant difference was observed in the 5-year survival rate between the low-and high-level groups (64.7% versus 61.1%, P50.801) (Figure 2 ). 1 T cells between the tumors-designated FIGO stage IIB and IIIB; no significant differences were observed between the groups or within the groups when the CD4 1 T cells were counted overall or separately in the stroma and tumor nest (Table 4) . However, although the number of CD4
1 TILs was significantly lower in the deceased group as compared with those in the surviving group, we found no statistically significant difference in the 5-year survival rate between the groups with high or low levels of CD4
1 TILs (76.5% versus 50.0%, P50.121) (Figure 4 (Figure 6 ). 1 TILs and survival. This result is in contrast with those from a number of studies that describe CD8
1 T lymphocytes as a favorable or non-favorable prognostic factor for survival. Piersma et al. 31 observed that the presence of intratumoral CD8 1 T cells in cervical cancer was correlated with the lack of pelvic lymph node spread and was, therefore, correlated indirectly with prognosis. A high number of tumor-infiltrating CD8
1 T lymphocytes were observed as a favorable prognostic factor for survival in some studies of human cancers, including endometrial cancer, 32 ovarian cancer, 8 colorectal cancer, 33 esophageal cancer 34 and urothelial carcinoma. 35 Other studies on non-small cell lung cancer, 36 anal squamous cell carcinoma 24 and renal cell carcinoma 37 reported that CD8 1 T lymphocytes were a negative prognostic factor.
The CD8 1 T-cell subpopulation has been considered to be the effector in the antitumor response; however, when the status of activation was explored, most of the cells were underprimed (CD45RO 1 ) 38 or inactivated (in this study, the GrB/CD8 ratio was 7/48), regardless of the effector/target ratio within the tumor tissue (data not shown). It is unlikely that such a weak functional population could eliminate the tumor burden. The similarity in the numbers of CD8 TILs between the two groups suggests that the recruitment of CD8 1 T cells to the tumor site occurs under similar conditions. More importantly, the similarity of the two cytotoxic markers (GrB and Prf) reflects that the cytotoxic machinery of the infiltrates was intact, suggesting that the dysfunctional status of the effector cells was due to the influence of the microenvironment 39 rather than to the physical dysfunction of signal transduction in the T cells. 40 Thus, the low expression of the T-cell receptor-f chain, the T cell-signaling molecule, observed in CD8
1
TILs of cervical cancer patients, may not be associated with chronic viral infection. 39 Interestingly, these results differ from our previous data regarding breast cancer, which revealed a significant discrepancy in the numbers of GrB-and Prf-positive cells. 41 The orchestration of these two molecules is known to be a prerequisite for CD8
1 T cells to exert their killing function. This indicates that the status of CTL in different malignant microenvironments requires further exploration. Clinical outcome in squamous cell carcinoma W Shah et al 64
The main mechanism by which TILs control tumor growth is postulated to be via a cytotoxic mechanism. In this scenario, the infiltration of the tumor site with high numbers of activated CD8 A low density of CD3 1 , CD4 1 and CD8 1 cells is associated with an increased risk of relapse in squamous cell cervical cancer, while a high density of all three cell types is associated with a decreased risk of relapse. 42 High numbers of CD4 1 TILs have also been observed as a favorable prognostic marker in other human cancers such as nonsmall cell lung cancer 36 and head and neck cancer. 43 The characteristics of CD4
1 Tregs and the mechanisms leading to their biological effects remain the subject of extensive investigation. 44, 45 In principle, Tregs may downregulate the antitumor immune response. Thus, increased Tregs within the primary tumor may predict a poor prognosis. Several studies in mice have shown that Tregs inhibit the antitumor immune response [46] [47] [48] and that the depletion of Tregs can enhance effector T-cell antitumor responses. 49, 50 HPV-specific Tregs can be detected in both the draining lymph nodes and the tumors of women infected with HPV, and they seem to be another means to downregulate host immune responses. van der Burg et al. 51 isolated HPV-specific CD4 1 T cells from lymph node biopsies of cervical cancer patients and found that they had the ability to suppress proliferation and cytokine (IFN-c and IL-2) production by responder T cells. The capacity of HPV-specific CD4
1 T cells to exert this suppressive effect depended on their activation by cognate HPV antigen and on close-range interactions with responder T cells. HPV-specific CD4
Tregs were also retrieved from cervical cancer biopsies, suggesting that they may interfere with the antitumor immune responses on both the induction and effector levels. Notably, the relationship between Tregs and cervical cancer is unknown, but many of these data support a role for Tregs in disease progression.
An earlier study by Sheu et al. 52 showed that reversed CD4/CD8 ratios of TILs are correlated with the progression of human cervical carcinoma; the study found that the CD4/CD8 ratios of TILs were reversed in both cervical squamous cell carcinoma and cervical adenocarcinoma. The proportion of CD4 1 T cells was significantly lower in tumors from patients with lymph node metastases than in those from patients without lymph node metastases, as was the reversed CD4/ CD8 ratio. Similarly, Piersma et al. 31 found a significantly stronger CD8 1 T-cell tumor infiltration, a higher CD8 1 /CD4 1 T-cell ratio, and a higher CD8 1 /Tregs ratio in patients with tumors that failed to metastasize to the tumor-draining lymph node. Loddenkemper et al., 27 in a comparison study of high-grade CIN (CIN III) and cervical carcinoma with colon cancer, skin melanoma and bronchial carcinoma, revealed that HPV-derived lesions have a significantly higher number of infiltrating lymphocytes and FOXP3
1 Tregs as compared with three other common tumor types. Similar to the above studies, in our study, we observed a reversed CD4/CD8 ratio in cervical cancer. The overall mean number of CD4 1 /CD8 1 T-cell ratios than in patients with low CD4
1 /CD8 1 T-cell ratios. The generation of a specific cytotoxic T-cell response is known to depend on sufficient help from activated Th1-type CD4 1 T cells. 53, 54 The inability of the host to reject a tumor may be due to the insufficient generation of tumor-specific CD4 1 T cells. 55, 56 The relatively low number of Th1-type CD4 1 T cells with reversed CD4/CD8 ratios in the deceased group in our study supports this hypothesis. Unitt et al. 57 observed that a high CD4
1 /CD8 1 T-cell ratio is associated with a reduced risk of tumor recurrence after liver transplantation in hepatocellular carcinoma. Our results obviously reflect the cancerous environment per se and demonstrate that the analysis of the functional phenotypes of TILs 'in situ' may more precisely describe the tumor milieu. However, the mechanism by which Tregs influence the functional maturation of CD8 1 T cells remains to be explored because there were no differences in the numbers of activated CD8
1 T cells among all of the studied groups. Clinical outcome in squamous cell carcinoma W Shah et al 65
